KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Oscar Health (OSCR) Shares Outstanding (Diluted Average) (2020 - 2025)

Historic Shares Outstanding (Diluted Average) for Oscar Health (OSCR) over the last 6 years, with Q4 2025 value amounting to $262.4 million.

  • Oscar Health's Shares Outstanding (Diluted Average) fell 130.34% to $262.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was $262.4 million, marking a year-over-year decrease of 130.34%. This contributed to the annual value of $262.4 million for FY2025, which is 130.34% down from last year.
  • Oscar Health's Shares Outstanding (Diluted Average) amounted to $262.4 million in Q4 2025, which was down 130.34% from $259.3 million recorded in Q3 2025.
  • Oscar Health's Shares Outstanding (Diluted Average)'s 5-year high stood at $305.9 million during Q1 2025, with a 5-year trough of $88.9 million in Q1 2021.
  • Moreover, its 5-year median value for Shares Outstanding (Diluted Average) was $220.5 million (2023), whereas its average is $233.7 million.
  • As far as peak fluctuations go, Oscar Health's Shares Outstanding (Diluted Average) skyrocketed by 61779.16% in 2021, and later tumbled by 1399.39% in 2025.
  • Quarter analysis of 5 years shows Oscar Health's Shares Outstanding (Diluted Average) stood at $179.0 million in 2021, then rose by 18.72% to $212.5 million in 2022, then increased by 4.32% to $221.7 million in 2023, then rose by 19.94% to $265.9 million in 2024, then decreased by 1.3% to $262.4 million in 2025.
  • Its Shares Outstanding (Diluted Average) stands at $262.4 million for Q4 2025, versus $259.3 million for Q3 2025 and $270.2 million for Q2 2025.